Facebook Twitter
Search

Part 1: Managing Non-Multiple Sclerosis Patients in a Multiple Sclerosis Practice: Rare Neuroimmunological Disorders – Everything You Need to Know Course

Presented by 

Daniel Reich, MD, PhD

Activity Overview

Year

2026

CREDIT HOURS

2.0

CREDIT/S AVAILABLE

AAPA, ACPE, ANCC, APA, ASWB, CME, RD, IPCE, Certificate of Completion

Level of Information

Basic, Intermediate

Duration

Course Duration: 1h32m

Track/s

Categories 2026, MS Management, Science of MS
$70.00
  • Duration
    1 hour32 minutes
  • Last Updated
    August 19, 2026

About This Activity

This session will introduce participants to the biologic and clinical basics of rare neuroimmune conditions such as neuromyelitis optic, anti-MOG associated disorder, autoimmune encephalitis, myelitis, neurosarcoidosis and stiff person syndrome. Participants will be educated about diagnostic criteria and appropriate testing as well as therapeutic options. Access to care and drug access programs will be reviewed and a focus on multidisciplinary care will be used to review and discuss best practices.

Target Audience

  • This activity has been designed to meet the educational needs of physicians, advanced practice clinicians, nursing professionals, pharmacists, psychologists, social workers, rehabilitation specialists, dietitians, researchers, advocates, and other members of the healthcare team involved in the management of patients with MS.

Learning Objectives

  • Compare MS models of care in order to support the provision of team-based, comprehensive care via the most appropriate model for a given practice setting that appropriately incorporates roles and responsibilities of clinicians and ensures the delivery of evidence-based MS care.
  • Summarize methods to monitor treatment outcomes including patient self-report, automated self-assessment, data from wearable devices, clinician reported outcomes, imaging, and biomarkers in order to optimize their utilization in clinical practice and research.
  • Review the current understanding of diagnostic criteria, phenotypes, and variants of MS and other neuroimmune conditions to promote accurate diagnosis, initiation of appropriate therapy and monitoring of outcomes.
  • Identify the roles and interactions of genetics and epigenetics, the microbiome, environmental factors, age, comorbidities, and risk behaviors as factors contributing to pathogenesis and course of neuroimmune conditions including MS, MOGAD, NMOSD, and other disorders.

Course Content

Managing Non-Multiple Sclerosis Patients in a Multiple Sclerosis Practice: Rare Neuroimmunological Disorders – Everything You Need to Know Part 1

  • Introduction to Rare Neuroimmune Disorders
    55:14
  • 2025 Updates to Diagnostic Criteria and Nosology for Myelitis
    36:02